Effects of endothelin receptor blockade and COX inhibition on intestinal I/R injury in a rat model: Experimental research
- 16 September 2020
- journal article
- research article
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 83, 89-97
Abstract
Background: Intestinal ischemia is a highly morbid and mortal condition with no specific treatment. The present study aimed to investigate the effects of cyclooxygenase (COX) inhibition synchronized with nitric oxide (NO) release and endothelin (ET) receptor blockade on oxidative stress, inflammation, vasoconstriction, and bacterial translocation which occur during ischemia-reperfusion (I/R) injury in in-vivo rat intestinal I/R model. Materials and methods 36 male Wistar rats were randomly divided into six groups (n = 6). Superior mesenteric artery blood flow (SMABF) was recorded; SMA was occluded for 30 min; SMABF was re-recorded at the beginning of the reperfusion phase. Rats were sacrificed after the reperfusion period of 60 min. Blood and tissue samples were obtained. Acetylsalicylic acid (ASA), NO-ASA, flurbiprofen (FLUR), and Tezosentan (TS) were administered 15 min after ischemia. Histopathological examination, bacterial translocation, and biochemical analysis were performed in plasma and tissue samples. Results: SMABF difference, mean Chiu's score and bacterial translocation were increased in the I/R group and decreased in the treatment groups. Plasma LDH, transaminases, intestinal fatty acid-binding protein (I-FABP), TNF-α, ICAM-1, interferon-gamma (IFN-Ɣ) and proinflammatory cytokine panel; tissue lipid peroxidation, MPO, xanthine oxidase (XO), NO, NF-kB levels and the expression of TNF-α were significantly elevated in the I/R group and markedly decreased in the treatment groups. The tissue antioxidant status was decreased in the I/R group and increased in the treatment groups. Conclusion: It is suggested that NO-ASA, TS, and FLUR can be introduced as promising therapeutics to improve intestinal I/R injury. Institutional protocol no 2018-29-05 (Animal Experimentations Ethics Committee, Hacettepe University).Keywords
This publication has 36 references indexed in Scilit:
- The interaction between endothelin-1 and nitric oxide in the vasculature: new perspectivesAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2011
- NO-releasing NSAIDs suppress NF-κB signaling in vitro and in vivo through S-nitrosylationCancer Letters, 2010
- Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal ResearchPLOS Biology, 2010
- Human Intestinal Ischemia-Reperfusion–Induced Inflammation CharacterizedThe American Journal of Pathology, 2010
- Myeloperoxidase Modulates Endothelin Receptor Type B ExpressionFree Radical Biology and Medicine, 2010
- Pitavastatin prevents intestinal ischemia/reperfusion–induced bacterial translocation and lung injury in atherosclerotic rats with hypoadiponectinemiaSurgery, 2009
- Role of TNF-α-induced reactive oxygen species in endothelial dysfunction during reperfusion injuryAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- The lipid peroxidation end‐product 4‐HNE induces COX‐2 expression through p38MAPK activation in 3T3‐L1 adipose cellFEBS Letters, 2007
- Endothelin‐1 enhances oxidative stress, cell proliferation and reduces apoptosis in human umbilical vein endothelial cells: role of ETB receptor, NADPH oxidase and caveolin‐1British Journal of Pharmacology, 2005
- Nitric Oxide–Releasing Aspirin Derivative, NCX 4016, Promotes Reparative Angiogenesis and Prevents Apoptosis and Oxidative Stress in a Mouse Model of Peripheral IschemiaArteriosclerosis, Thrombosis, and Vascular Biology, 2004